S&P 500   4,553.83 (-0.89%)
DOW   36,079.90 (-0.46%)
QQQ   383.28 (-1.71%)
AAPL   187.79 (-1.80%)
MSFT   364.90 (-2.57%)
META   315.13 (-2.98%)
GOOGL   128.05 (-2.89%)
AMZN   143.68 (-2.28%)
TSLA   235.15 (-1.54%)
NVDA   452.76 (-3.18%)
NIO   7.28 (+1.82%)
BABA   73.12 (-1.18%)
AMD   116.87 (-3.72%)
T   16.64 (-0.72%)
F   10.76 (+1.70%)
MU   73.75 (-2.87%)
CGC   0.70 (+13.71%)
GE   121.41 (-0.89%)
DIS   92.07 (-0.55%)
AMC   6.98 (+1.75%)
PFE   29.56 (+2.25%)
PYPL   59.53 (-0.20%)
XOM   102.47 (-0.50%)
S&P 500   4,553.83 (-0.89%)
DOW   36,079.90 (-0.46%)
QQQ   383.28 (-1.71%)
AAPL   187.79 (-1.80%)
MSFT   364.90 (-2.57%)
META   315.13 (-2.98%)
GOOGL   128.05 (-2.89%)
AMZN   143.68 (-2.28%)
TSLA   235.15 (-1.54%)
NVDA   452.76 (-3.18%)
NIO   7.28 (+1.82%)
BABA   73.12 (-1.18%)
AMD   116.87 (-3.72%)
T   16.64 (-0.72%)
F   10.76 (+1.70%)
MU   73.75 (-2.87%)
CGC   0.70 (+13.71%)
GE   121.41 (-0.89%)
DIS   92.07 (-0.55%)
AMC   6.98 (+1.75%)
PFE   29.56 (+2.25%)
PYPL   59.53 (-0.20%)
XOM   102.47 (-0.50%)
S&P 500   4,553.83 (-0.89%)
DOW   36,079.90 (-0.46%)
QQQ   383.28 (-1.71%)
AAPL   187.79 (-1.80%)
MSFT   364.90 (-2.57%)
META   315.13 (-2.98%)
GOOGL   128.05 (-2.89%)
AMZN   143.68 (-2.28%)
TSLA   235.15 (-1.54%)
NVDA   452.76 (-3.18%)
NIO   7.28 (+1.82%)
BABA   73.12 (-1.18%)
AMD   116.87 (-3.72%)
T   16.64 (-0.72%)
F   10.76 (+1.70%)
MU   73.75 (-2.87%)
CGC   0.70 (+13.71%)
GE   121.41 (-0.89%)
DIS   92.07 (-0.55%)
AMC   6.98 (+1.75%)
PFE   29.56 (+2.25%)
PYPL   59.53 (-0.20%)
XOM   102.47 (-0.50%)
S&P 500   4,553.83 (-0.89%)
DOW   36,079.90 (-0.46%)
QQQ   383.28 (-1.71%)
AAPL   187.79 (-1.80%)
MSFT   364.90 (-2.57%)
META   315.13 (-2.98%)
GOOGL   128.05 (-2.89%)
AMZN   143.68 (-2.28%)
TSLA   235.15 (-1.54%)
NVDA   452.76 (-3.18%)
NIO   7.28 (+1.82%)
BABA   73.12 (-1.18%)
AMD   116.87 (-3.72%)
T   16.64 (-0.72%)
F   10.76 (+1.70%)
MU   73.75 (-2.87%)
CGC   0.70 (+13.71%)
GE   121.41 (-0.89%)
DIS   92.07 (-0.55%)
AMC   6.98 (+1.75%)
PFE   29.56 (+2.25%)
PYPL   59.53 (-0.20%)
XOM   102.47 (-0.50%)

Neogen Stock Price, News & Analysis (NASDAQ:NEOG)

$17.58
+0.14 (+0.80%)
(As of 11:22 AM ET)
Compare
Today's Range
$17.00
▼
$17.72
50-Day Range
$14.65
▼
$19.46
52-Week Range
$14.37
▼
$24.09
Volume
205,303 shs
Average Volume
1.71 million shs
Market Capitalization
$3.80 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.75
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Neogen MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
29.4% Upside
$22.75 Price Target
Short Interest
Bearish
6.23% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Neogen in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$334,100 Bought Last Quarter
Proj. Earnings Growth
32.20%
From $0.59 to $0.78 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

357th out of 952 stocks

Diagnostic Substances Industry

4th out of 13 stocks

See Top Rated MarketRank™ Stocks Here

NEOG stock logo

About Neogen Stock (NASDAQ:NEOG)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

NEOG Stock Price History

NEOG Stock News Headlines

December 1, 2023 | finance.yahoo.com
Neogen (NEOG) Unveils New Assay for Walnut Allergens Detection
November 30, 2023 | finance.yahoo.com
Neogen® Launches Highly Sensitive Quantitative ELISA Assay for the Detection of Walnut Allergens
December 4, 2023 | DTI Trader (Ad)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
November 21, 2023 | finance.yahoo.com
Neogen® to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 17, 2023 | msn.com
Neogen's (NEOG) Innovation Aids, Currency Headwind Stays
November 9, 2023 | finance.yahoo.com
Neogen (NEOG) Up 3.6% Since Last Earnings Report: Can It Continue?
October 31, 2023 | finance.yahoo.com
The past three years for Neogen (NASDAQ:NEOG) investors has not been profitable
October 26, 2023 | finance.yahoo.com
Insider Buying: Douglas Jones Acquires 10,000 Shares of Neogen Corp
December 4, 2023 | DTI Trader (Ad)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
October 17, 2023 | seekingalpha.com
Neogen Struggling Through An Awkward Transition
October 17, 2023 | msn.com
Piper Sandler Maintains Neogen (NEOG) Neutral Recommendation
October 16, 2023 | markets.businessinsider.com
Piper Sandler Sticks to Its Hold Rating for Neogen (NEOG)
October 13, 2023 | proactiveinvestors.com
Neogen set make a quiet start to new financial year
October 12, 2023 | finance.yahoo.com
Neogen Corporation (NASDAQ:NEOG) Q1 2024 Earnings Call Transcript
October 12, 2023 | finance.yahoo.com
Insider Buying: CFO David Naemura Acquires 10,000 Shares of Neogen Corp
October 11, 2023 | seekingalpha.com
Neogen says CFO Naemura buys 10K shares
October 11, 2023 | finance.yahoo.com
Neogen (NEOG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
October 11, 2023 | finance.yahoo.com
Q1 2024 Neogen Corp Earnings Call
October 10, 2023 | markets.businessinsider.com
Crude Oil Moves Lower; Neogen Posts Downbeat Results
October 10, 2023 | finance.yahoo.com
Neogen Corp (NEOG) Reports First-Quarter 2024 Results: Revenue Soars by 73%
October 10, 2023 | msn.com
Neogen Reports Mixed Quarterly Results, Affirms Guidance
October 10, 2023 | msn.com
Neogen (NASDAQ:NEOG) Drops on Disappointing Q1 Numbers
October 10, 2023 | markets.businessinsider.com
Why Is Food Safety Firm Neogen Stock Trading Lower Today?
October 10, 2023 | finance.yahoo.com
Here's Why Neogen (NEOG) is Poised for a Turnaround After Losing -14.43% in 4 Weeks
October 10, 2023 | finance.yahoo.com
Unveiling Neogen (NEOG)'s Value: Is It Really Priced Right? A Comprehensive Guide
October 10, 2023 | seekingalpha.com
Neogen Corporation 2024 Q1 - Results - Earnings Call Presentation
October 10, 2023 | finanznachrichten.de
Neogen Corporation: Neogen Announces First-Quarter 2024 Results
See More Headlines
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/10/2023
Today
12/04/2023
Next Earnings (Estimated)
1/04/2024
Fiscal Year End
5/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
CIK
711377
Web
www.neogen.com
Phone
(517) 372-9200
Fax
517-372-2006
Employees
2,640
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$22.75
High Stock Price Target
$28.00
Low Stock Price Target
$17.50
Potential Upside/Downside
+30.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
29.56
P/E Growth
N/A
Net Income
$-22,870,000.00
Net Margins
-2.89%
Pretax Margin
-2.94%
Return on Equity
3.57%
Return on Assets
2.46%

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
4.23
Quick Ratio
3.21

Sales & Book Value

Annual Sales
$822.45 million
Price / Sales
4.59
Cash Flow
$0.91 per share
Price / Cash Flow
19.17
Book Value
$14.49 per share
Price / Book
1.20

Miscellaneous

Outstanding Shares
216,310,000
Free Float
214,775,000
Market Cap
$3.77 billion
Optionable
Optionable
Beta
1.10

Social Links

7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report














NEOG Stock Analysis - Frequently Asked Questions

Should I buy or sell Neogen stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NEOG shares.
View NEOG analyst ratings or view top-rated stocks.

What is Neogen's stock price target for 2024?

2 equities research analysts have issued 12-month price objectives for Neogen's stock. Their NEOG share price targets range from $17.50 to $28.00. On average, they expect the company's stock price to reach $22.75 in the next year. This suggests a possible upside of 29.4% from the stock's current price.
View analysts price targets for NEOG or view top-rated stocks among Wall Street analysts.

How have NEOG shares performed in 2023?

Neogen's stock was trading at $15.23 at the beginning of 2023. Since then, NEOG stock has increased by 15.4% and is now trading at $17.58.
View the best growth stocks for 2023 here.

When is Neogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 4th 2024.
View our NEOG earnings forecast.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) announced its quarterly earnings data on Tuesday, October, 10th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.08. The firm earned $229 million during the quarter, compared to analyst estimates of $231.10 million. Neogen had a positive trailing twelve-month return on equity of 3.57% and a negative net margin of 2.89%. The company's revenue was up 72.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.15 earnings per share.

What ETFs hold Neogen's stock?

ETFs with the largest weight of Neogen (NASDAQ:NEOG) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), iShares Emergent Food and AgTech Multisector ETF (IVEG), VanEck Agribusiness ETF (MOO), Franklin U.S. Small Cap Multifactor Index ETF (FLQS), ProShares MSCI Transformational Changes ETF (ANEW), iShares Russell 2000 Value ETF (IWN), Invesco S&P MidCap 400 GARP ETF (EWMC) and iShares Russell 2000 ETF (IWM).

When did Neogen's stock split?

Neogen's stock split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly minted shares were issued to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

What guidance has Neogen issued on next quarter's earnings?

Neogen issued an update on its FY 2024 earnings guidance on Tuesday, October, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $955.00 million-$985.00 million, compared to the consensus revenue estimate of $968.41 million.

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

Who are Neogen's major shareholders?

Neogen's stock is owned by many different institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.03%), Bamco Inc. NY (2.81%), Morgan Stanley (2.64%), Mackenzie Financial Corp (2.48%), William Blair Investment Management LLC (2.22%) and JPMorgan Chase & Co. (1.85%). Insiders that own company stock include Bruce Papesh, Darci L Vetter, David H Naemura, Douglas Edward Jones, James P Tobin, Jason Warren Lilly, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical and William T Boehm.
View institutional ownership trends.

How do I buy shares of Neogen?

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:NEOG) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -